Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal ...

“Our proprietary intranasal platform has the potential to enhance drug delivery bioavailability. We believe that intranasal delivery has the potential to improve patient outcomes by providing a ...

Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced ...

Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal ...

Raanana, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

Check a company’s competitiveness in the job market with alternative data that tracks hiring, job openings, and more.

The Israeli Standards Institute approval (Standard 6230 Type Approval) is a critical milestone, as it enables PORTO EV riders as young as 16 to operate the vehicle without requiring a driver’s ...

Xylo's affiliations in the medical solutions arena include ownership in Polyrizon Ltd. The Company's affiliates in digital commerce include Gix Internet Ltd. and Eventer Technologies Ltd. In the ...

Polyrizon Ltd. (NASDAQ:POLY), a biopharmaceutical company, announced today the appointment of Liron Carmel to its Board of Directors, effective immediately. Mr. Carmel, who brings a wealth of ...